BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Mufemilast readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Mufemilast\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05486104-54@assetmemo.bio
DTSTAMP:20261121T004103Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:Mufemilast: Phase 2 readout est. (NCT05486104)
DESCRIPTION:Mufemilast\, phase 2\, Ulcerative Colitis.\nStudy: Phase II Stu
 dy of Hemay005 in Patients With Active Ulcerative Colitis\nEstimated prima
 ry completion: 30 December 2026. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/mufemilast#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT05486104
URL:https://assetmemo.bio/drug/mufemilast#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07314242-54@assetmemo.bio
DTSTAMP:20261121T004103Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Mufemilast: Phase 2 readout est. (NCT07314242)
DESCRIPTION:Mufemilast\, phase 2.\nStudy: A Study to Investigate the Biomar
 kers of Hemay005 in Adult Participants With Moderate to Severe COPD\nEstim
 ated primary completion: 31 December 2027. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/mufemilast#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07314242
URL:https://assetmemo.bio/drug/mufemilast#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07650942-54@assetmemo.bio
DTSTAMP:20261121T004103Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:Mufemilast: Phase 3 readout est. (NCT07650942)
DESCRIPTION:Mufemilast\, phase 3\, Ulcerative Colitis.\nStudy: Hemay005 for
  the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis
 \nEstimated primary completion: May 2028. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/mufemilast#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07650942
URL:https://assetmemo.bio/drug/mufemilast#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
